REVENUES

6 Months Ended

Jun. 30, 2018

Income Statement [Abstract]

REVENUES

NOTE 5 – REVENUES (AS RESTATED)

The following table summarizes the Company’s disaggregation of revenues:

	Six Months Ended June 30,
(U.S. dollars in thousands)	2018		2017
Pfizer	$	3,986	$	5,671
Brazil	$	2,573	$	3,576
Total revenues from selling goods	$	6,559	$	9,247
Revenues from license and R&D services	$	4,993